Oliver Klein

6PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 24, 2026
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trial.

|Jan 24, 2023
Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?

Oliver Klein, Damien Kee, Adnan Nagrial

|Jul 06, 2022
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma.

Prachi Bhave, Tasnia Ahmed, Serigne N Lo

|Jun 06, 2022
Talimogene laherparepvec resulting in near-complete response in a patient with treatment-refractory Merkel cell carcinoma.

Michael A Cilento, Oliver Klein, Elizabeth Egan

|Nov 16, 2021
Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial.

Oliver Klein, Damien Kee, Bo Gao

|Jul 14, 2020
Complete response of metastatic pleomorphic dermal sarcoma to anti-PD-1 therapy.

O Klein, C McTigue, Z W Wong

Pageof 1

Frequent Collaborators

1 joint publications

Jessica da Gama Duarte

1 joint publications

Michael A Cilento

1 joint publications

Prachi Bhave

1 joint publications

Serigne N Lo